Drugs /
ascorbic acid
Overview
Clinical Trials
Ascorbic acid has been investigated in 8 clinical trials, of which 6 are open and 2 are closed. Of the trials investigating ascorbic acid, 1 is phase 1 (1 open), 2 are phase 1/phase 2 (2 open), and 5 are phase 2 (3 open).
TET2 Loss, TET2 Mutation, and BRCA1 Loss (germline) are the most frequent biomarker inclusion criteria for ascorbic acid clinical trials.
Myelodysplastic syndromes, acute myeloid leukemia, and ampulla of vater adenocarcinoma are the most common diseases being investigated in ascorbic acid clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.